CN1828300A - 生物传感器 - Google Patents
生物传感器 Download PDFInfo
- Publication number
- CN1828300A CN1828300A CNA200410003625XA CN200410003625A CN1828300A CN 1828300 A CN1828300 A CN 1828300A CN A200410003625X A CNA200410003625X A CN A200410003625XA CN 200410003625 A CN200410003625 A CN 200410003625A CN 1828300 A CN1828300 A CN 1828300A
- Authority
- CN
- China
- Prior art keywords
- solution
- examined
- biology sensor
- clearance portion
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 136
- 210000003850 cellular structure Anatomy 0.000 claims description 38
- 238000003317 immunochromatography Methods 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 25
- 230000015572 biosynthetic process Effects 0.000 claims description 24
- 238000001035 drying Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 15
- 239000011148 porous material Substances 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 8
- 238000012423 maintenance Methods 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 230000004941 influx Effects 0.000 claims description 4
- 239000007844 bleaching agent Substances 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 61
- 238000005259 measurement Methods 0.000 abstract description 22
- 238000007689 inspection Methods 0.000 abstract description 10
- 239000003550 marker Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 266
- 239000010410 layer Substances 0.000 description 100
- 210000004369 blood Anatomy 0.000 description 34
- 239000008280 blood Substances 0.000 description 34
- 238000006243 chemical reaction Methods 0.000 description 26
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 21
- 238000012360 testing method Methods 0.000 description 20
- 238000001514 detection method Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 210000002700 urine Anatomy 0.000 description 15
- 108010074051 C-Reactive Protein Proteins 0.000 description 13
- 102100032752 C-reactive protein Human genes 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- 239000000020 Nitrocellulose Substances 0.000 description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 12
- 229920001220 nitrocellulos Polymers 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 230000001413 cellular effect Effects 0.000 description 10
- 230000008602 contraction Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000000123 paper Substances 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000010241 blood sampling Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000008676 import Effects 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 239000001103 potassium chloride Substances 0.000 description 6
- 235000011164 potassium chloride Nutrition 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 5
- 239000003365 glass fiber Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 229920000139 polyethylene terephthalate Polymers 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 229920002799 BoPET Polymers 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 239000011229 interlayer Substances 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 3
- 230000002860 competitive effect Effects 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 229940045872 sodium percarbonate Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000011923 Thyrotropin Human genes 0.000 description 2
- 108010061174 Thyrotropin Proteins 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000004186 food analysis Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000004856 soil analysis Methods 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- -1 urine Substances 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000606752 Pasteurellaceae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000431 corpus luteum hormone Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 238000009603 uroscopy Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/97—Test strip or test slide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (17)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000157049 | 2000-05-26 | ||
JP2000157049 | 2000-05-26 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB018014372A Division CN1161611C (zh) | 2000-05-26 | 2001-05-25 | 生物传感器 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1828300A true CN1828300A (zh) | 2006-09-06 |
CN100533147C CN100533147C (zh) | 2009-08-26 |
Family
ID=18661748
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB018014372A Expired - Fee Related CN1161611C (zh) | 2000-05-26 | 2001-05-25 | 生物传感器 |
CNB200410003625XA Expired - Fee Related CN100533147C (zh) | 2000-05-26 | 2001-05-25 | 生物传感器 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB018014372A Expired - Fee Related CN1161611C (zh) | 2000-05-26 | 2001-05-25 | 生物传感器 |
Country Status (7)
Country | Link |
---|---|
US (1) | US7575915B2 (zh) |
EP (1) | EP1202059B1 (zh) |
JP (1) | JP3553045B2 (zh) |
KR (1) | KR100505803B1 (zh) |
CN (2) | CN1161611C (zh) |
DE (1) | DE60121404T2 (zh) |
WO (1) | WO2001090754A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112740039A (zh) * | 2018-09-27 | 2021-04-30 | 积水医疗株式会社 | 免疫层析试验片 |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071384B2 (en) | 1997-12-22 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Control and calibration solutions and methods for their use |
US20050103624A1 (en) | 1999-10-04 | 2005-05-19 | Bhullar Raghbir S. | Biosensor and method of making |
US20020137200A1 (en) | 2000-06-01 | 2002-09-26 | Mie Takahashi | Biosensor and blood component analyzing method |
US7112451B2 (en) | 2000-06-28 | 2006-09-26 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
EP1353181B1 (en) * | 2001-08-10 | 2012-07-04 | Panasonic Corporation | Biosensor and method for analyzing blood components using it |
WO2003083479A1 (fr) * | 2002-03-29 | 2003-10-09 | Matsushita Electric Industrial Co., Ltd. | Procede et dispositif de traitement du sang, procede et dispositif de mesure des hemoglobines |
CN1318142C (zh) * | 2002-10-11 | 2007-05-30 | Zbx公司 | 诊断装置 |
JP2004189665A (ja) * | 2002-12-11 | 2004-07-08 | Matsushita Electric Ind Co Ltd | 抗c反応性タンパク質抗体、この抗体を用いたバイオセンサ、この抗体の作製方法、及びこの抗体を用いた免疫測定方法 |
EP1447665B1 (en) * | 2003-02-11 | 2016-06-29 | Bayer HealthCare LLC | Method for reducing effect of hematocrit on measurement of an analyte in whole blood |
US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
MXPA05013635A (es) | 2003-06-20 | 2006-02-24 | Hoffmann La Roche | Metodo y reactivo para producir tiras reactivas estrechas y homogeneas. |
US8148164B2 (en) | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US7645373B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostic Operations, Inc. | System and method for coding information on a biosensor test strip |
US8206565B2 (en) | 2003-06-20 | 2012-06-26 | Roche Diagnostics Operation, Inc. | System and method for coding information on a biosensor test strip |
US8058077B2 (en) | 2003-06-20 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Method for coding information on a biosensor test strip |
US7645421B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8071030B2 (en) | 2003-06-20 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
US8679853B2 (en) | 2003-06-20 | 2014-03-25 | Roche Diagnostics Operations, Inc. | Biosensor with laser-sealed capillary space and method of making |
US7718439B2 (en) | 2003-06-20 | 2010-05-18 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
MXPA06013233A (es) | 2004-05-14 | 2007-02-28 | Bayer Healthcare Llc | Metodos para realizar un ajuste del hematocrito en ensayos de glucosa y dispositivos para los mismos. |
US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
KR100680267B1 (ko) | 2005-09-16 | 2007-02-08 | 주식회사 인포피아 | 식별정보를 포함하는 바이오 센서 및 바이오 센서의식별정보 판독장치 |
EP2034318B1 (en) | 2006-06-26 | 2013-09-04 | Nippon Telegraph and Telephone Corporation | Flow cell and process for manufacturing the same |
CN101105495B (zh) * | 2007-07-31 | 2011-06-15 | 浙江省肿瘤医院 | 肿瘤标志物质控品的制备方法 |
JP4840398B2 (ja) * | 2008-04-25 | 2011-12-21 | 富士電機株式会社 | 抗原の分離装置並びにこれを利用した抗原の計測方法及び装置 |
US8303910B2 (en) * | 2008-05-07 | 2012-11-06 | Panasonic Corporation | Biosensor |
WO2009136476A1 (ja) | 2008-05-07 | 2009-11-12 | パナソニック株式会社 | バイオセンサの製造方法およびバイオセンサ |
JP5036867B2 (ja) * | 2008-05-26 | 2012-09-26 | パナソニック株式会社 | バイオセンサ |
KR101894100B1 (ko) * | 2012-02-29 | 2018-08-31 | 고려대학교 산학협력단 | 바이오 센서 |
FR3012982B1 (fr) * | 2013-11-08 | 2015-12-25 | Espci Innov | Procede de stockage et de concentration d'un compose volatil |
JP6417725B2 (ja) * | 2014-06-06 | 2018-11-07 | 凸版印刷株式会社 | 分析対象物の検出方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754658A (fr) * | 1969-08-12 | 1971-02-10 | Merck Patent Gmbh | Lamelle indicatrice, se composant d'une matiere capillaire impregnee, absorbante et gainee de feuilles |
US4252538A (en) * | 1979-03-02 | 1981-02-24 | Engineering & Research Associates, Inc. | Apparatus and method for antibody screening, typing and compatibility testing of red blood cells |
GB2204398B (en) | 1987-04-27 | 1991-08-28 | Unilever Plc | Analytical test device for use in assays |
US4883764A (en) * | 1987-07-20 | 1989-11-28 | Kloepfer Mary A | Blood test strip |
US5416000A (en) * | 1989-03-16 | 1995-05-16 | Chemtrak, Inc. | Analyte immunoassay in self-contained apparatus |
US5234813A (en) * | 1989-05-17 | 1993-08-10 | Actimed Laboratories, Inc. | Method and device for metering of fluid samples and detection of analytes therein |
JP3070764B2 (ja) * | 1990-03-12 | 2000-07-31 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | 生物学的検定装置及びそれを用いた検定方法 |
US5166051A (en) * | 1990-08-08 | 1992-11-24 | Genesis Labs, Inc. | Membranes, membrane overlays for exclusion of erythrocytes, and method for immunoassay of whole blood analytes |
US5607863A (en) | 1991-05-29 | 1997-03-04 | Smithkline Diagnostics, Inc. | Barrier-controlled assay device |
JP2948318B2 (ja) * | 1992-03-10 | 1999-09-13 | クイデル コーポレイション | 特異的結合アッセイ用の赤血球の分離方法 |
EP0653625B1 (en) | 1993-11-12 | 2002-09-11 | Inverness Medical Switzerland GmbH | Reading devices for teststrips |
US5569608A (en) * | 1995-01-30 | 1996-10-29 | Bayer Corporation | Quantitative detection of analytes on immunochromatographic strips |
JPH08285849A (ja) * | 1995-04-14 | 1996-11-01 | Mochida Pharmaceut Co Ltd | 簡易測定装置およびこれを用いる測定方法 |
AU6248796A (en) * | 1995-05-19 | 1996-11-29 | Universal Health-Watch, Inc. | Rapid self-contained assay format |
EP0889751B1 (en) * | 1996-04-03 | 1999-09-08 | The Perkin-Elmer Corporation | Device and method for multiple analyte detection |
JPH10274653A (ja) | 1997-03-28 | 1998-10-13 | Sanko Junyaku Kk | イムノクロマトグラフィによる検体の画像処理定量方 法 |
US5985675A (en) * | 1997-12-31 | 1999-11-16 | Charm Sciences, Inc. | Test device for detection of an analyte |
JP3655990B2 (ja) | 1997-07-28 | 2005-06-02 | アボットジャパン株式会社 | 免疫分析装置 |
KR100292182B1 (ko) * | 1997-09-18 | 2001-11-26 | 모리시타 요이찌 | 면역크로마토그라피장치 |
US6194224B1 (en) * | 1998-07-27 | 2001-02-27 | Avitar, Inc. | Diagnostic membrane containing fatty acid sarcosinate surfactant for testing oral fluid |
JP4233686B2 (ja) | 1999-06-11 | 2009-03-04 | 日水製薬株式会社 | イムノクロマトグラフィー装置のハウジング |
JP4223163B2 (ja) | 1999-10-25 | 2009-02-12 | パナソニック株式会社 | 免疫クロマトグラフィー試験片、及びクロマトグラフ分析方法 |
-
2001
- 2001-05-25 CN CNB018014372A patent/CN1161611C/zh not_active Expired - Fee Related
- 2001-05-25 DE DE60121404T patent/DE60121404T2/de not_active Expired - Lifetime
- 2001-05-25 JP JP2001586467A patent/JP3553045B2/ja not_active Expired - Fee Related
- 2001-05-25 WO PCT/JP2001/004419 patent/WO2001090754A1/ja active IP Right Grant
- 2001-05-25 US US10/031,988 patent/US7575915B2/en not_active Expired - Fee Related
- 2001-05-25 CN CNB200410003625XA patent/CN100533147C/zh not_active Expired - Fee Related
- 2001-05-25 EP EP01934357A patent/EP1202059B1/en not_active Expired - Lifetime
- 2001-05-25 KR KR10-2002-7001064A patent/KR100505803B1/ko not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112740039A (zh) * | 2018-09-27 | 2021-04-30 | 积水医疗株式会社 | 免疫层析试验片 |
Also Published As
Publication number | Publication date |
---|---|
CN1161611C (zh) | 2004-08-11 |
US7575915B2 (en) | 2009-08-18 |
EP1202059B1 (en) | 2006-07-12 |
CN1380976A (zh) | 2002-11-20 |
US20020137230A1 (en) | 2002-09-26 |
DE60121404D1 (en) | 2006-08-24 |
KR20020042623A (ko) | 2002-06-05 |
JP3553045B2 (ja) | 2004-08-11 |
EP1202059A1 (en) | 2002-05-02 |
KR100505803B1 (ko) | 2005-08-04 |
WO2001090754A1 (fr) | 2001-11-29 |
DE60121404T2 (de) | 2007-02-15 |
EP1202059A4 (en) | 2003-01-15 |
CN100533147C (zh) | 2009-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1161611C (zh) | 生物传感器 | |
CN100492010C (zh) | 生物传感器 | |
JP4383860B2 (ja) | バイオセンサ、及び測定方法 | |
EP2284538B1 (en) | Biosensor | |
CN103954751B (zh) | 纸基微流控免疫传感器芯片和现场及时检测免疫分析平台 | |
JP3126383B2 (ja) | 簡易な分析装置 | |
CN101738465B (zh) | 用于分析液相和固相之间的生物反应的方法和装置 | |
US20070087450A1 (en) | Immuno-gold lateral flow assay | |
KR101254512B1 (ko) | 면역 크로마토그래피용 시험구 및 이것을 사용한 반정량방법 | |
KR100596278B1 (ko) | 바이오센서 및 이를 사용한 혈액 성분 분석 방법 | |
JP2006215017A (ja) | 非連続式免疫分析装置及びこれを利用した免疫分析方法 | |
US20110045578A1 (en) | Method of manufacturing biosensor and biosensor produced thereby | |
JP2006521547A (ja) | 多チャンネル試験器、その製造法及びその使用 | |
EP2270508B1 (en) | Membrane assay method and kit | |
JP2009258095A (ja) | クロマトグラフィー分析用ストリップの製造方法 | |
WO2006043614A1 (ja) | メンブランエンザイムイムノアッセイ法 | |
JPS63210664A (ja) | 酸素要求検出系を用いる装置のための乾燥試験片及び被検流体中の分析成分の検出方法 | |
JP4365329B2 (ja) | 複数の被検出物を検出する簡易アッセイ装置及び方法 | |
JP4769171B2 (ja) | 体液試料濾過分離装置及び方法 | |
JPH01223352A (ja) | 固相酵素免疫検定システムおよび方法 | |
WO2018056700A1 (ko) | 반응과 분석을 포함한 단일 진단칩의 고감도 신속진단방법 | |
JP2005257468A (ja) | バイオセンサ | |
US12044679B2 (en) | Diagnostic assay methods using assay device having microreactor | |
US20240069024A1 (en) | Diagnostic assay methods using assay device having microreactor | |
CN106596984A (zh) | 全自动荧光免疫法术前四项测定***及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: PANASONIC HEALTHCARE + MEDICAL EQUIPMENT CO., LTD. Free format text: FORMER OWNER: MATSUSHITA ELECTRIC INDUSTRIAL CO, LTD. Effective date: 20140520 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140520 Address after: Ehime Prefecture, Japan Patentee after: Panasonic Healthcare Co., Ltd Address before: Osaka Japan Patentee before: Matsushita Electric Industrial Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: PANASONIC HEALTHCARE HOLDINGS CO., LTD. Free format text: FORMER OWNER: PANASONIC HEALTHCARE + MEDICAL EQUIPMENT CO., LTD. Effective date: 20150414 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150414 Address after: Tokyo, Japan Patentee after: Panasonic's health medical treatment is controlled interest Co., Ltd. Address before: Ehime Prefecture, Japan Patentee before: Panasonic Healthcare Co., Ltd |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090826 Termination date: 20160525 |
|
CF01 | Termination of patent right due to non-payment of annual fee |